Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | PIM1 | P11309 | 5/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 3/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25733722 | 0.89 | KDM4E (0.50) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL22172198 | 0.88 | CYP1B1 (0.52) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL24888400 | 0.88 | KDM4E (0.51) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL23314510 | 0.88 | CYP1A1 (0.51) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL13562027 | 0.87 | CYP2A6 (0.44) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL24156104 | 0.85 | CYP1B1 (0.59) | CYP1A1CYP1B1CYP1A2KDM4EPIM1 | |
| SCHEMBL22650689 | 0.85 | KDM4E (0.47) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL29344301 | 0.83 | CYP1B1 (0.47) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL25733726 | 0.83 | CYP1A1 (0.48) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 | |
| SCHEMBL12070495 | 0.82 | CYP1B1 (0.49) | CYP1A1CYP1B1CYP1A2KDM4ECYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| WO-2023287228-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-19 | — | — | WO | disclosed |
| US-20220416174-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
| WO-2022045743-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2022-03-03 | — | — | WO | disclosed |
| WO-2021033970-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, NR1D1 | CYP1A1 8/4885CYP1B1 43/4885CYP1A2 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.